Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator Initiated Registry of Simple Oral Therapy for Low Risk Breast Cancer (SOLR)

NCT03238703 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT03238703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03238703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator Initiated Registry of Simple Oral Therapy for Low Risk Breast Cancer (SOLR)
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 4
Overall status
Withdrawn
Start date
September 1, 2018
Completion date
March 14, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2/neu negative, invasive breast carcinoma, postmenopausal, stage 0 breast cancer, stage ia breast cancer